HealthEquity, Inc. (HQY) News
Filter HQY News Items
HQY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HQY News Highlights
- HQY's 30 day story count now stands at 20.
- Over the past 22 days, HQY's stories per day has been in a clear uptrend, growing by about 0.13 per day.
- The most mentioned tickers in articles about HQY are HAE, ITGR and QDEL.
Latest HQY News From Around the Web
Below are the latest news stories about HEALTHEQUITY INC that investors may wish to consider to help them evaluate HQY as an investment opportunity.
3 Reasons to Hold Zimmer Biomet (ZBH) Stock in Your PortfolioZimmer Biomet's (ZBH) focus on emerging markets raises optimism about the stock. |
Does HealthEquity (HQY) Have the Potential to Rally 31.37% as Wall Street Analysts Expect?The consensus price target hints at a 31.4% upside potential for HealthEquity (HQY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. |
3 Amazing Health Service Stocks to Brave "Labordemic" in 2024Here are the three stocks, MEDP, ELV and HQY, which have the potential to shield your portfolio from the impact of healthcare staffing challenges in 2024. |
5 MedTech Stocks Poised to Continue Their Winning Streaks in 2024Stocks like DexCom Inc. (DXCM), Integer Holdings (ITGR), Penumbra (PEN), Haemonetics (HAE), Health Equity (HAE) and are likely to continue their strong performance in 2024. |
McKesson (MCK) Announces Availability of PNH's FDA-Approved DrugThe availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for PNH. |
Former Director Ian Sacks Sells 45,000 Shares of HealthEquity Inc (HQY)Ian Sacks, a former director of HealthEquity Inc (NASDAQ:HQY), has sold 45,000 shares of the company on December 19, 2023, according to a recent SEC Filing. |
Here's Why You Should Retain Veeva Systems (VEEV) Stock NowVeeva Systems' (VEEV) strong product portfolio raises optimism about the stock. |
HealthEquity (HQY) Performed Strongly in Q3Wasatch Global Investors, an investment management firm, released its “Wasatch Small Cap Growth Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here. Stocks fell broadly in the quarter as investors worried about the consequences of rising interest rates and a possible recession. During the quarter, the strategy declined but […] |
QuidelOrtho's (QDEL) Latest FDA Nod to Boost Diagnostic TestingQuidelOrtho's (QDEL) receipt of the FDA's latest approval is likely to improve clinical care, provide cost savings and deliver sample-to-result molecular testing across all laboratory settings. |
Veeva Systems (VEEV) Vault Quality Offerings Adopted by RecipharmVeeva Systems' (VEEV) Vault Quality Suite applications are expected to aid Recipharm in boosting its operational efficiencies. |